Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination Therapy
Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy of anastrozole monotherapy versus
maximal oestrogen blockade with combinated therapy of fulvestrant and anastrozole compared
with in treatment of hormone receptor positive women with first relapse of breast cancer.